Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
1701
DELISTED
Apellis Pharmaceuticals
APLS
| $17.1M | 0.01% |
518,811
+100,145
| +24% | +$5.63M |
|
1702
Genworth Financial
GNW
$3.76B
| $17.1M | 0.01% |
4,553,201
+52,103
| +1% | +$186K |
|
1703
ESCO Technologies
ESE
$7.79B
| $17M | 0.01% |
220,769
+6,755
| +3% | +$598K |
|
1704
Evolent Health
EVH
$496M
| $17M | 0.01% |
547,283
+5,672
| +1% | +$136K |
|
1705
Oxford Industries
OXM
$545M
| $16.9M | 0.01% |
187,479
-5,597
| -3% | -$509K |
|
|
SCS
1706
DELISTED
Steelcase
SCS
| $16.9M | 0.01% |
1,333,055
+55,293
| +4% | +$763K |
|
|
RPT
1707
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $16.8M | 0.01% |
1,319,890
-6,900
| -0.5% | -$87.9K |
|
1708
AAR Corp
AIR
$5.86B
| $16.8M | 0.01% |
519,185
+62,024
| +14% | +$2.13M |
|
1709
Zentalis Pharmaceuticals
ZNTL
$303M
| $16.8M | 0.01% |
252,550
+98,286
| +64% | +$5.67M |
|
|
MDRX
1710
DELISTED
Veradigm Inc. Common Stock
MDRX
| $16.8M | 0.01% |
1,256,655
-95,345
| -7% | -$1.54M |
|
|
INN
1711
Summit Hotel Properties
INN
$653M
| $16.8M | 0.01% |
1,743,970
+36,488
| +2% | +$334K |
|
1712
Rambus
RMBS
$10.9B
| $16.8M | 0.01% |
755,376
-24,633
| -3% | -$580K |
|
|
VRS
1713
DELISTED
Verso Corporation
VRS
| $16.8M | 0.01% |
807,953
+27,377
| +4% | +$528K |
|
|
MTOR
1714
DELISTED
MERITOR, Inc.
MTOR
| $16.8M | 0.01% |
786,433
+41,604
| +6% | +$969K |
|
1715
Knowles
KN
$3.29B
| $16.7M | 0.01% |
893,478
+19,836
| +2% | +$388K |
|
|
MTTR
1716
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $16.7M | 0.01% |
+885,129
| New | +$14.4M |
|
1717
Century Communities
CCS
$2.02B
| $16.7M | 0.01% |
271,476
+7,098
| +3% | +$471K |
|
1718
Central Garden & Pet Co Class A
CENTA
$2.43B
| $16.7M | 0.01% |
484,915
+22,746
| +5% | +$786K |
|
1719
Provident Financial Services
PFS
$3.25B
| $16.7M | 0.01% |
710,308
+29,037
| +4% | +$641K |
|
|
LTC
1720
LTC Properties
LTC
$2.1B
| $16.6M | 0.01% |
523,979
+19,666
| +4% | +$703K |
|
1721
Andersons Inc
ANDE
$2.22B
| $16.6M | 0.01% |
537,708
-13,590
| -2% | -$392K |
|
1722
PennyMac Financial
PFSI
$4.13B
| $16.5M | 0.01% |
270,403
-10,214
| -4% | -$649K |
|
|
OCDX
1723
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $16.5M | 0.01% |
893,801
+271,220
| +44% | +$5.46M |
|
1724
Methode Electronics
MEI
$603M
| $16.5M | 0.01% |
391,683
-14,660
| -4% | -$672K |
|
1725
Kirby Corp
KEX
$7.24B
| $16.5M | 0.01% |
343,350
+3,721
| +1% | +$206K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.